Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation

[1]  A. Basu,et al.  A Common Carcinogen Benzo[a]pyrene Causes Neuronal Death in Mouse via Microglial Activation , 2010, PloS one.

[2]  V. Perry,et al.  Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.

[3]  Guy C. Brown,et al.  Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons , 2010, Molecular Neurobiology.

[4]  A. Basu,et al.  Japanese Encephalitis Virus Induce Immuno-Competency in Neural Stem/Progenitor Cells , 2009, PloS one.

[5]  L. Chao,et al.  Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression* , 2009, The Journal of Biological Chemistry.

[6]  V. Yang,et al.  Prostaglandin E2 and Krüppel‐like transcription factors synergistically induce the expression of decay‐accelerating factor in intestinal epithelial cells , 2008, Immunology.

[7]  Y. Liu,et al.  KLF4 PROMOTES THE EXPRESSION, TRANSLOCATION, AND RELEASE OF HMGB1 IN RAW264.7 MACROPHAGES IN RESPONSE TO LPS , 2008, Shock.

[8]  E. Tham,et al.  Differential regulation of Krüppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: Effects of endothelin-1, oxidative stress and cytokines , 2008, Biochimica et biophysica acta.

[9]  M. Hüll,et al.  Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: Evidence for uncoupled regulation of mPGES‐1 and COX‐2 , 2008, Glia.

[10]  X. Chen,et al.  Krüppel-like Factor 4 Is Acetylated by p300 and Regulates Gene Transcription via Modulation of Histone Acetylation* , 2007, Journal of Biological Chemistry.

[11]  A. Lupo,et al.  Differential expression and cellular localization of ZNF224 and ZNF255, two isoforms of the Krüppel-like zinc-finger protein family. , 2007, Gene.

[12]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[13]  A. Basu,et al.  Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis , 2007, Glia.

[14]  E. Edelman,et al.  Kruppel-like Factor 4 Regulates Endothelial Inflammation* , 2007, Journal of Biological Chemistry.

[15]  G. Downey,et al.  Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. , 2007, Free radical biology & medicine.

[16]  Jeppe Falsig,et al.  The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions , 2006, Journal of Neuroimmunology.

[17]  T. Joh,et al.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.

[18]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[19]  D. Kuhn,et al.  Dopamine Quinones Activate Microglia and Induce a Neurotoxic Gene Expression Profile , 2006, Annals of the New York Academy of Sciences.

[20]  Sucharita SenBanerjee,et al.  Kruppel-like Factor 4 Is a Mediator of Proinflammatory Signaling in Macrophages* , 2005, Journal of Biological Chemistry.

[21]  M. Hannink,et al.  Distinct signaling pathways for induction of type II NOS by IFNγ and LPS in BV-2 microglial cells , 2005, Neurochemistry International.

[22]  C. Jefferies,et al.  Bruton's Tyrosine Kinase Is Involved in p65-mediated Transactivation and Phosphorylation of p65 on Serine 536 during NFκB Activation by Lipopolysaccharide* , 2005, Journal of Biological Chemistry.

[23]  K. Mielke,et al.  c‐Jun N‐terminal kinases (JNKs) mediate pro‐inflammatory actions of microglia , 2005, Glia.

[24]  R. Simone,et al.  Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation , 2005, Brain Research Reviews.

[25]  Li Zhong,et al.  Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. , 2005, Blood.

[26]  Asima Bhattacharyya,et al.  Toll-like Receptor 2 and Mitogen- and Stress-activated Kinase 1 Are Effectors of Mycobacterium avium-induced Cyclooxygenase-2 Expression in Macrophages* , 2004, Journal of Biological Chemistry.

[27]  F. Luscinskas,et al.  KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation , 2004, The Journal of experimental medicine.

[28]  S. Shukla,et al.  Suppression of Constitutive and Tumor Necrosis Factor α-Induced Nuclear Factor (NF)-κB Activation and Induction of Apoptosis by Apigenin in Human Prostate Carcinoma PC-3 Cells: Correlation with Down-Regulation of NF-κB-Responsive Genes , 2004, Clinical Cancer Research.

[29]  V. Yang,et al.  Requirement of Krüppel-like Factor 4 in Preventing Entry into Mitosis following DNA Damage* , 2004, Journal of Biological Chemistry.

[30]  N. Sicotte,et al.  Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis , 2004, Journal of Neuroimmunology.

[31]  J. Berman,et al.  Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. , 2003, Methods.

[32]  V. Yang,et al.  Krüppel-like Factor 4 Mediates p53-dependent G1/S Cell Cycle Arrest in Response to DNA Damage* , 2003, The Journal of Biological Chemistry.

[33]  M. Carson.  Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis , 2002, Glia.

[34]  J. Leysen,et al.  Expression and regulation of interleukin‐10 and interleukin‐10 receptor in rat astroglial and microglial cells , 2002, The European journal of neuroscience.

[35]  Jonathan R. Enterline,et al.  Transforming growth factor β1 prevents IL‐1β–induced microglial activation, whereas TNFα‐ and IL‐6–stimulated activation are not antagonized , 2002 .

[36]  T. Tanabe,et al.  Cyclooxygenase isozymes and their gene structures and expression. , 2002, Prostaglandins & other lipid mediators.

[37]  Nathalie Perreault,et al.  The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. , 2002, Development.

[38]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[39]  Y. Surh,et al.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. , 2001, Mutation research.

[40]  J. Mestre,et al.  Redundancy in the Signaling Pathways and Promoter Elements Regulating Cyclooxygenase-2 Gene Expression in Endotoxin-treated Macrophage/Monocytic Cells* , 2001, The Journal of Biological Chemistry.

[41]  S. Rhee,et al.  Murine TOLL-like Receptor 4 Confers Lipopolysaccharide Responsiveness as Determined by Activation of NFκB and Expression of the Inducible Cyclooxygenase* , 2000, The Journal of Biological Chemistry.

[42]  U. Gimsa,et al.  Phagocytosis of neuronal or glial debris by microglial cells: Upregulation of MHC class II expression and multinuclear giant cell formation in vitro , 2000, Glia.

[43]  Y. Masuho,et al.  Identification and characterization of human ZNF274 cDNA, which encodes a novel kruppel-type zinc-finger protein having nucleolar targeting ability. , 2000, Genomics.

[44]  P. Cohen,et al.  Role of Mitogen-Activated Protein Kinase Cascades in Mediating Lipopolysaccharide-Stimulated Induction of Cyclooxygenase-2 and IL-1β in RAW264 Macrophages1 , 2000, The Journal of Immunology.

[45]  H. Sakurai,et al.  IκB Kinases Phosphorylate NF-κB p65 Subunit on Serine 536 in the Transactivation Domain* , 1999, The Journal of Biological Chemistry.

[46]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[47]  Elaine Fuchs,et al.  Klf4 is a transcription factor required for establishing the barrier function of the skin , 1999, Nature Genetics.

[48]  D. Malo,et al.  Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes. , 1999, Trends in genetics : TIG.

[49]  T. Petrova,et al.  Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Rothe,et al.  Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes* , 1999, The Journal of Biological Chemistry.

[51]  J. Bonventre,et al.  Expression of the Transcriptional Repressor Protein Kid-1 Leads to the Disintegration of the Nucleolus* , 1999, The Journal of Biological Chemistry.

[52]  C. Iadecola,et al.  Permissive and obligatory roles of NO in cerebrovascular responses to hypercapnia and acetylcholine. , 1996, The American journal of physiology.

[53]  J. M. Shields,et al.  Identification and Characterization of a Gene Encoding a Gut-enriched Krüppel-like Factor Expressed during Growth Arrest* , 1996, The Journal of Biological Chemistry.

[54]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[55]  C. Patterson,et al.  Suppression of Interleukin-1β-induced Nitric-oxide Synthase Promoter/Enhancer Activity by Transforming Growth Factor-β1 in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[56]  H. Herschman.  Prostaglandin synthase 2. , 1996, Biochimica et biophysica acta.

[57]  C. Cooper,et al.  Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase , 1994, FEBS letters.

[58]  T. Kishimoto,et al.  Interleukin-6 and its receptor in autoimmunity. , 1992, Journal of autoimmunity.

[59]  L. Garcia-Segura,et al.  Selective estrogen receptor modulators decrease the production of interleukin‐6 and interferon‐γ‐inducible protein‐10 by astrocytes exposed to inflammatory challenge in vitro , 2010, Glia.

[60]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[61]  C. Jefferies,et al.  Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide. , 2005, The Journal of biological chemistry.

[62]  S. Shukla,et al.  Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[63]  Jonathan R. Enterline,et al.  Transforming growth factor beta1 prevents IL-1beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. , 2002, Glia.

[64]  P. Cohen,et al.  Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. , 2000, Journal of immunology.

[65]  H. Sakurai,et al.  IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. , 1999, The Journal of biological chemistry.

[66]  C. Patterson,et al.  Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB. , 1996, The Journal of biological chemistry.

[67]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.